Syndecan-1 (CD138) Immunoreactivity in Bone Marrow Biopsies of Multiple Myeloma: Shed Syndecan-1 Accumulates in Fibrotic Regions
Open Access
- 1 October 2001
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 14 (10) , 1052-1058
- https://doi.org/10.1038/modpathol.3880435
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Measurement of apoptosis and proliferation of bone marrow plasma cells in patients with plasma cell proliferative disordersBritish Journal of Haematology, 1999
- Regulated Shedding of Syndecan-1 and -4 Ectodomains by Thrombin and Growth Factor Receptor ActivationPublished by Elsevier ,1997
- INTERACTION OF TUMOR AND HOST CELLS WITH ADHESION AND EXTRACELLULAR MATRIX MOLECULES IN THE DEVELOPMENT OF MULTIPLE MYELOMAHematology/Oncology Clinics of North America, 1997
- A plasmocyte selective monoclonal antibody (B‐B4) recognizes syndecan‐1British Journal of Haematology, 1996
- Heparan Sulfate-mediated Cell AggregationJournal of Biological Chemistry, 1995
- The ins and outs of fibroblast growth factorsCell, 1994
- Immunocytochemistry of cell surface heparan sulfate proteoglycan in mouse tissues. A light and electron microscopic study.Journal of Histochemistry & Cytochemistry, 1987
- Cytoplasmic immunoglobulin content in multiple myeloma.Journal of Clinical Investigation, 1985
- Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and stagingBritish Journal of Haematology, 1982
- Quantitation of Bone Marrow Reticulin—A Normal RangeAmerican Journal of Clinical Pathology, 1971